×
戻る Agenda
Session 1 : Regulation and Future Perspectives
Session Chair(s)
Kazuhiko Mori, PhD, MSc
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
Speaker(s)
Nicholas Richardson, DO, MPH
Clinical Team Leader, Division of Hematologic Malignancies 2, OND, CDER, FDA, United States
Looking Forward : A FDA Perspective for Master Protocols
Rami Suzuki, PhD
Chief Executive Officer, Japan and Representative Director, Ferring Pharmaceuticals Co., Ltd., Japan
Master Protocol and Cohort Ready Trials for Neuroscience
Daisuke Sato
Coordinator, Office of Review Management, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Regulation and Present Profile of Clinical Trials for Approval of Pharmaceuticals in Japan